NCT05410522

Brief Summary

This study aims to evaluate rectus femoris muscle mass in lung transplant recipients and the effect of a training program during ICU admission based on the use of electrical muscle stimulation (EMS)

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
58

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 9, 2022

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

May 25, 2022

Completed
14 days until next milestone

First Posted

Study publicly available on registry

June 8, 2022

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 21, 2023

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2024

Completed
Last Updated

June 8, 2022

Status Verified

May 1, 2022

Enrollment Period

1.6 years

First QC Date

May 25, 2022

Last Update Submit

June 6, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Variation of muscle mass in the quadriceps

    The quadriceps muscle mass of the lung transplant recipient will be measured prior to transplantation and will be monitored in the first 24 hours post-transplant and every 7 days from admission until hospital discharge.

    Up to 6 months prior to transplantation, within 24 hours of admission and every seven days and/or until discharge from the ICU (up to 14 days).

Secondary Outcomes (2)

  • Mobility assessment according to ICU-Mobility scale (IMS)

    Each day in the morning and afternoon, until discharge from ICU (up to 14 days).

  • Leg strength according to Chair and Stand test

    Up to 6 months prior to transplantation and at ICU discharge (up to 14 days)

Study Arms (2)

Experimental lung transplant

EXPERIMENTAL

The training time will be 30 minutes in the morning and 30 minutes in the afternoon with a total daily work time of 60 minutes. The frequency of work will be different in each session, seeking in the morning routine a vascularization and improvement of muscle trophism and in the afternoon an aerobic endurance, activation of the working capacity of the tonic muscles to improve the stabilizing muscles and postural fitness.

Device: EMS Program

Control lung transplant

NO INTERVENTION

Electro stimulation therapy will not be performed.

Interventions

Lower limb electrostimulation therapy is scheduled for lung transplant patients. The therapy consists in the application of 2 daily 30-minute sessions that begin in the first 48 hours post-transplantation and are maintained daily until discharge from the hospital.

Experimental lung transplant

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Admitted to the lung transplant list according to the criteria of the Health System.
  • Those who attend the rehabilitation consultation of the hospital under study to undergo treatment prior to transplantation.
  • They must receive the graft at the hospital under study and be admitted to the resuscitation unit at the same center for post-surgical follow-up.

You may not qualify if:

  • Those who are rejected from the transplant list or deceased before the implant is performed.
  • Lack of follow-up by the rehabilitation consultation.
  • Are receiving treatment with muscle relaxants after admission to the ICU.
  • Present skin alterations incompatible with EMS.
  • Contraindications to perform the transplant proposed according to the criteria of the Health System.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Universitario 12 de Octubre

Madrid, 28041, Spain

RECRUITING

Related Publications (5)

  • De Brandt J, Spruit MA, Hansen D, Franssen FM, Derave W, Sillen MJ, Burtin C. Changes in lower limb muscle function and muscle mass following exercise-based interventions in patients with chronic obstructive pulmonary disease: A review of the English-language literature. Chron Respir Dis. 2018 May;15(2):182-219. doi: 10.1177/1479972317709642. Epub 2017 Jun 5.

  • Shah S, Darekar B, Salvi S, Kowale A. Quadriceps strength in patients with chronic obstructive pulmonary disease. Lung India. 2019 Sep-Oct;36(5):417-421. doi: 10.4103/lungindia.lungindia_27_19.

  • Maury G, Langer D, Verleden G, Dupont L, Gosselink R, Decramer M, Troosters T. Skeletal muscle force and functional exercise tolerance before and after lung transplantation: a cohort study. Am J Transplant. 2008 Jun;8(6):1275-81. doi: 10.1111/j.1600-6143.2008.02209.x. Epub 2008 Apr 29.

  • Zhang L, Hu W, Cai Z, Liu J, Wu J, Deng Y, Yu K, Chen X, Zhu L, Ma J, Qin Y. Early mobilization of critically ill patients in the intensive care unit: A systematic review and meta-analysis. PLoS One. 2019 Oct 3;14(10):e0223185. doi: 10.1371/journal.pone.0223185. eCollection 2019.

  • Janaudis-Ferreira T, Mathur S, Deliva R, Howes N, Patterson C, Rakel A, So S, Wickerson L, White M, Avitzur Y, Johnston O, Heywood N, Singh S, Holdsworth S. Exercise for Solid Organ Transplant Candidates and Recipients: A Joint Position Statement of the Canadian Society of Transplantation and CAN-RESTORE. Transplantation. 2019 Sep;103(9):e220-e238. doi: 10.1097/TP.0000000000002806.

Study Officials

  • Virginia Díaz-Teruel, MsD

    Hospital Universitario 12 de Octubre

    PRINCIPAL INVESTIGATOR
  • Ignacio Zaragoza-García, PhD

    Universidad Complutense de Madrid

    STUDY DIRECTOR

Central Study Contacts

Ignacio Zaragoza García, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 25, 2022

First Posted

June 8, 2022

Study Start

May 9, 2022

Primary Completion

December 21, 2023

Study Completion

June 30, 2024

Last Updated

June 8, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will not share

Locations